alexa Risk stratification of apolipoprotein B, apolipoprotein A1, and apolipoprotein B AI ratio on the prevalence of the metabolic syndrome: the ATTICA study.
Nutrition

Nutrition

Journal of Nutritional Disorders & Therapy

Author(s): Pitsavos C, Panagiotakos DB, Skoumas J, Papadimitriou L, Stefanadis C, Pitsavos C, Panagiotakos DB, Skoumas J, Papadimitriou L, Stefanadis C, Pitsavos C, Panagiotakos DB, Skoumas J, Papadimitriou L, Stefanadis C, Pitsavos C, Panagiotakos DB, Skoumas J, Papadimitriou L, Stefanadis C

Abstract Share this page

Abstract We investigated the association of apolipoproteins AI and B in relation to the prevalence of metabolic syndrome in a random sample of cardiovascular disease- free adults from the ATTICA study (1,514 men, aged 18-87 y; 1,528 women, aged 18-89 y). Metabolic syndrome was defined according to the National Cholesterol Education Program Adult Treatment Panel III criteria. The prevalence of metabolic syndrome was 25\% in men and 15\% in women (P < .001). Using the area under the Receiver Operation Characteristic curve, apolipoprotein B/AI was the best diagnostic marker of metabolic syndrome, the optimal discriminating cut-off value of this ratio was 0.72 (sensitivity 74\%, specificity 67\%), and individuals with apolipoprotein B/AI ratio greater than 0.74 had 3.29 times higher odds of having metabolic syndrome (95\% confidence interval: 2.56-4.21) after adjusting for potential confounders. This article was published in Angiology and referenced in Journal of Nutritional Disorders & Therapy

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords